M15-555
Indication examinée dans l’étude: polyarthrite rhumatoïde
Phase: phase 3
Titre de l’étude:
A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) in Subjects With Moderately to Severely Active Rheumatoide Arthritis With Inadequate Response to MTX
Numéro EudraCT: 2015-003376-75